Why digital procurement is a game changer for the pharmaceutical industry

22 June 2021
amazon_big

Dave Brittain, head of Amazon Business UK & Ireland, provides an Expert View exploring the potential for the pharmaceutical and healthcare industries to improve their efficiency through digital procurement.

Over the past few decades, there’s hardly a sector that has not been revolutionized by technology in some way, shape or form. When we think about tech innovation, we imagine seismic steps that disrupt market conditions and fundamentally reshape entire industries.

However, it’s often the smaller, evolutionary steps that have the biggest and most direct impact on businesses – especially when creating new efficiencies and streamlining processes to save money.

A good example of this is the digitalization of procurement, which saves organizations a huge amount of time, cost and energy – particularly for healthcare and pharma industries.

Why does digital procurement matter?

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

Today's issue

Company Spotlight





More Features in Pharmaceutical